# Intranasal Oxytocin Intervention for Caregivers to Persons With Dementia

> **NCT06364228** · PHASE2 · RECRUITING · sponsor: **University of Nebraska** · enrollment: 32 (estimated)

## Conditions studied

- Stress

## Interventions

- **DRUG:** Placebo
- **DRUG:** Oxytocin Intranasal Spray 12 International Unit (12IU)
- **DRUG:** Oxytocin Intranasal Spray 24 International Unit (24IU)
- **PROCEDURE:** Functional MRI

## Key facts

- **NCT ID:** NCT06364228
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-20
- **Primary completion:** 2027-05
- **Final completion:** 2027-06
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06364228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06364228, "Intranasal Oxytocin Intervention for Caregivers to Persons With Dementia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06364228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*